LaVoie Health Science Blog

SEPTEMBER 20, 2024

By: Magnus Stakkestad When I arrived in Boston in early June, I was highly aware of the city’s unique life science ecosystem, given that it’s home to some of the world’s leading universities, research institutes, hospitals, and businesses. These industries are highly regulated, and the road to FDA approval is long and expensive.

Biotech 52

Biotech Biotechnology Life science Government 52

Frost & Sullivan

MAY 9, 2025

billion in 2024, is projected to grow at a CAGR of 10.7%, reaching $122.13 This article explores the key trends, market drivers, and emerging opportunities in the pharmaceutical clinical contract peripheral services market from 2024 to 2030. The global CRO industry, valued at $66.39 billion by 2030.

Mergers and acquisition activities 52

Mergers and acquisition activities Biopharma Biotechnology Biotech 52

Frost & Sullivan

MARCH 28, 2025

This article explores key trends, growth opportunities, and market drivers in the cardiac biomarkers diagnostics industry from 2024 to 2029. Competitive Landscape: Industry Players and Ecosystem The global cardiac biomarkers diagnostics market is moderately competitive, with major players driving innovation.

Biotechnology 52

Biotechnology Biotech Ecosystems 52

Frost & Sullivan

JANUARY 23, 2025

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors.

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52